EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs

Giovanna Maria Stanfoca Casagrande iD, Marcela de Oliveira Silva, Rui Manuel Reis iD, Letícia Ferro Leal iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032505 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Giovanna Maria Stanfoca Casagrande und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology Research Center, Barretos Cancer Hospital, 1331 Rua Antenor Duarte Vilela, Barretos 14784-400, Brazil. Hauptthemen laut MEDLINE: Lung Neoplasms, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 147-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Programa Nacional de Apoio à atenção ao Câncer (PRONON), Sao Paulo Research Foundation (FAPESP), National Ministry of Health (Brazil).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is the deadliest cancer worldwide. Tissue biopsy is currently employed for the diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive approach to determine biomarkers from body fluids, such as blood, urine, sputum, and saliva. Tumor cells release cfDNA, ctDNA, exosomes, miRNAs, circRNAs, CTCs, and DNA methylated fragments, among others, which can be successfully used as biomarkers for diagnosis, prognosis, and prediction of treatment response. Predictive biomarkers are well-established for managing lung cancer, and liquid biopsy options have emerged in the last few years. Currently, detecting EGFR p.(Tyr790Met) mutation in plasma samples from lung cancer patients has been used for predicting response and monitoring tyrosine kinase inhibitors (TKi)-treated patients with lung cancer. In addition, many efforts continue to bring more sensitive technologies to improve the detection of clinically relevant biomarkers for lung cancer. Moreover, liquid biopsy can dramatically decrease the turnaround time for laboratory reports, accelerating the beginning of treatment and improving the overall survival of lung cancer patients. Herein, we summarized all available and emerging approaches of liquid biopsy—techniques, molecules, and sample type—for lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCell-Free Nucleic AcidsHumansEarly Detection of CancerBiomarkers, TumorLiquid Biopsy

Stichwörter der Autor:innen

biomarkersliquid biopsylung cancerprecision medicine

Substanzen

Biomarkers, TumorCell-Free Nucleic Acids

Autor:innen und Institutionen

  • Molecular Oncology Research Center, Barretos Cancer Hospital, 1331 Rua Antenor Duarte Vilela, Barretos 14784-400, Brazil.
  • Life and Health Sciences Research Institute (ICVS), School of Medicine, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal.
  • ICVS/3B's-PT Government Associate Laboratory, 4710-057 Braga, Portugal.
  • Barretos School of Medicine Dr. Paulo Prata-FACISB, Barretos 14785-002, Brazil.

ORCID-Profile: Giovanna Maria Stanfoca Casagrande, Rui Manuel Reis, Letícia Ferro Leal

Förderung

  • Programa Nacional de Apoio à atenção ao Câncer (PRONON)
  • Sao Paulo Research Foundation (FAPESP)
  • National Ministry of Health (Brazil)
  • Public Ministry of Labor Campinas (Research, Prevention, and Education of Occupational Cancer)
  • CNPq Productivity (Brazil) fellowship
  • PRONON—PRONON/MS (Abordagens móveis e de tecnologia para prevenção primária e secundária de câncer—NUP)

Zitieren

APA

Casagrande, G. M. S., Silva, M. O., Reis, R. M., & Leal, L. F. (2023). Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032505

Vancouver

Casagrande GMS, Silva MO, Reis RM, Leal LF. Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032505

BibTeX
@article{Casagrande2023,
  author = {Casagrande, Giovanna Maria Stanfoca and Silva, Marcela de Oliveira and Reis, Rui Manuel and Leal, Letícia Ferro},
  title = {Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032505}
}
Kostenlos starten →